Characteristics of factors, which worsen the clinical course and disturb the quality of life in patients with the combined pathology of asthma and chronic obstructive disease

Authors

  • Yuriy Feschenko SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080, Ukraine
  • Liudmyla Iashyna SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080, Ukraine
  • Ksenia Nazarenko SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080, Ukraine https://orcid.org/0000-0003-2116-2693
  • Svitlana Opimakh SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080, Ukraine

DOI:

https://doi.org/10.15587/2519-4798.2017.119938

Keywords:

combined bronchial-obstructive pathology, heavy course, short breath, life quality

Abstract

The article studies factors that complicate the clinical course and disturb the life quality of patients with the chronic bronchial-obstructive pathology. Aim. To study factors that complicate the clinical course and disturb the life quality of patients with ACC for their rational modification.

Materials and methods. All patients underwent: collection of anamnesis and general clinical examination, evaluation of the function of external respiration, clinical symptoms and risks.

Results. At this work there were found factors that complicate the clinical course and life quality of patients with combined bronchial-obstructive pathology, especially clinical ones, such as expressed short breath, decrease of tolerance to physical loads and functional parameters of the external respiration.  

Conclusions of this work correspond to introduced recommendations as to the treatment of patients with ACC: effective anti-inflammatory and broncholytic therapy with the special accent on timely detection and adequate treatment of a concomitant pathology

Author Biographies

Yuriy Feschenko, SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080

MD, Professor, Academics of NAMS of Ukraine, Head of department

Department of Pulmonology

Liudmyla Iashyna, SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080

MD, Professor, Head of department

Department of Diagnosis, Therapy and Clinical Pharmacology of Lung Diseases

Ksenia Nazarenko, SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080

PhD

Department of Pulmonology

Svitlana Opimakh, SE « F. G. Yanovsky National Institute of Phthisiology and Pulmonology NAMS of Ukraine » Amosova str., 10, Kyiv, Ukraine, 03080

PhD

Department of Diagnosis, Therapy and Clinical Pharmacology of Lung Diseases

References

  1. Hines, K. L., Peebles, R. S. (2017). Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence. Current Allergy and Asthma Reports, 17 (3). doi: 10.1007/s11882-017-0683-4
  2. Bujarski, S., Parulekar, A. D., Sharafkhaneh, A., Hanania, N. A. (2015). The Asthma COPD Overlap Syndrome (ACOS). Current Allergy and Asthma Reports, 15 (3). doi: 10.1007/s11882-014-0509-6
  3. Vorob'ev, K. (2014). Kolichestvennye harakteristiki klinicheskoy informatsii. Ukrainskyi medychnyi chasopys, 1, 95–102.
  4. Caillaud, D., Chanez, P., Escamilla, R., Burgel, P.-R., Court-Fortune, I. et. al. (2016). Asthma-COPD overlap syndrome (ACOS)vs“pure” COPD: a distinct phenotype? Allergy, 72 (1), 137–145. doi: 10.1111/all.13004
  5. Kurashima, K., Takaku, Y., Ohta, C., Takayanagi, N., Yanagisawa, T., Sugita, Y. (2016). COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome. International Journal of Chronic Obstructive Pulmonary Disease, 479–487. doi: 10.2147/copd.s97343
  6. Unifikovanyi klnichnyi protokol pervynnoi (vtorynnoi) spetsializovanoi, tretynnoi (vysokospetsializovanoi) medychnoi dopomohy ta medychnoi reabilitatsiy "Khronichne obstruktyvne zakhvoriuvannia leheni", zatverdzhenyi nakazom MOZ Ukrainy No. 555 vid 27.06.2013 "Pro zatverdzhennia standartyzatsiy medychnoi dopomohy pry KhOZL".
  7. Gavrisyuk, V. K. (2016). Respiratornaya nedostatochnost': mekhanizmy razvitiya, sposoby otsenki, oksigenoterapiya. Ukrainskyi pulmonolohichnyi zhurnal, 4, 56–58.
  8. Jones, P. W., Adamek, L., Nadeau, G., Banik, N. (2012). Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. European Respiratory Journal, 42 (3), 647–654. doi: 10.1183/09031936.00125612
  9. Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34 (3), 648–654. doi: 10.1183/09031936.00102509
  10. Ringbaek, T., Martinez, G., Lange, P. (2012). A Comparison of the Assessment of Quality of Life with CAT, CCQ, and SGRQ in COPD Patients Participating in Pulmonary Rehabilitation. COPD: Journal of Chronic Obstructive Pulmonary Disease, 9 (1), 12–15. doi: 10.3109/15412555.2011.630248
  11. EuroQol – a new facility for the measurement of health-related quality of life (1990). Health Policy, 16 (3), 199–208. doi: 10.1016/0168-8510(90)90421-9
  12. Brooks, R. (1996). EuroQol: the current state of play. Health Policy, 37 (1), 53–72. doi: 10.1016/0168-8510(96)00822-6
  13. GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2017. (2017). Pneumologie, 71 (01), 9–14. doi: 10.1055/s-0042-121903
  14. Global Initiative for Asthma – GINA 2017.
  15. Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A. et. al. (2004). The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 350 (10), 1005–1012. doi: 10.1056/nejmoa021322
  16. ATS Statement (2002). American Journal of Respiratory and Critical Care Medicine, 166 (1), 111–117. doi: 10.1164/ajrccm.166.1.at1102
  17. Review Manager 5 (RevMan 5) is the software used for preparing and maintaining Cochrane Reviews (2017). Cochrane community. Available at: http://community.cochrane.org/tools/review-production-tools/revman-5

Downloads

Published

2017-12-31

How to Cite

Feschenko, Y., Iashyna, L., Nazarenko, K., & Opimakh, S. (2017). Characteristics of factors, which worsen the clinical course and disturb the quality of life in patients with the combined pathology of asthma and chronic obstructive disease. ScienceRise: Medical Science, (12 (20), 18–23. https://doi.org/10.15587/2519-4798.2017.119938

Issue

No. 12 (20) (2017)

Section

Medical Science

License

Copyright (c) 2017 Yuriy Feschenko, Liudmyla Iashyna, Ksenia Nazarenko, Svitlana Opimakh

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.